American Journal of Transplantation

Article	Citations
OFC 23rd Winter Symposium	320
AJT Digest for Patients: Their Own Window into Key Research	303
Dual Kidney Transplantation from Extended Marginal Donors in the United States: An analysis of SRTR and Literature Review	281
Benefits Of Preemptive Transplantation In Older Patients with High KDPI Kidneys: Is Sooner Better Than Later?	276
Are we closer to abandoning protocol graft biopsies after pediatric liver transplantation?	210
Optimization of donor flow matching and portal modulation to decrease small for size syndrome in Living Donor Liver Transplant - A Single Center American Experience	205
Deceased Kidney Donors on Dialysis Create Opportunities for Renal Transplantation: A Single Center Experience	198
Outcomes By Epstein-Barr Virus Serostatus In Pediatric Kidney Transplantation	187
Induction of fetomaternal tolerance? Suppressing B cells!	142
Hereditary thrombotic thrombocytopenic purpura acquired through liver transplantation: A case report	132
De novo membranous nephropathy in a pig-to-baboon kidney xenograft: A new xenograft glomerulopathy	130
Pediatric cardiac xenotransplantation and stakeholder engagement	129
Increasing Azole-resistant environmental Aspergillus fumigatus in Denmark	119
Phage-display immunoprecipitation for precision mapping the autoreactome	117
Will the flu vaccine work this year?	115
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept	114
Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients	114
Effects of in vivo CXCR4 blockade and proteasome inhibition on bone marrow plasma cells in HLA-sensitized kidney transplant candidates	112
OPTN/SRTR 2021 Annual Data Report: COVID-19	110
New metrics to measure OPO performance are here: How do we ensure organizations receive feedback and improve organ donation?	109
Kaposi sarcoma herpesvirus inflammatory cytokine syndrome—a severe complication of an overlooked donor-derived infection	105
Accurate eplet identification is necessary for accurate risk assessment	104
Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: Results of a nationwide study	100
Short- and long-term complications after living donor ileal resection	94
Alloantibodies after simultaneous liver-kidney transplant: A story of primary nonfunction, retransplantation, and antibody-mediated rejection	94

Rethinking Lactate’s Role as a Post-Transplant Outcome Predictor During Normothermic Machine Perfusion: Science or Speculation?	93
Atezolizumab plus bevacizumab as a downstaging therapy for liver transplantation in hepatocellular carcinoma with portal vein thrombosis: The first report	91
Disulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation	83
International multicenter study of ultralow graft-to-recipient weight ratio grafts in adult living donor liver transplantation	82
Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA.2 wave	79
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients	76
DCDD heart transplantation with thoraco-abdominal normothermic regional perfusion and static cold storage: The experience in Spain	75
Eculizumab as a therapeutic approach for severe crescentic recurrence of immunoglobulin A nephropathy after kidney transplantation	74
Navigating challenges in recipient selection for end-chain kidneys	74
First case of rapidly fatal mpox from secondary (household) transmission in a kidney transplant recipient	68
Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020	68
Comparative outcomes for over 100 deceased donor kidney transplants from SARS-CoV-2 positive donors: A single-center experience	68
Polymicrobial bacteremia in a heart transplant recipient: More than what meets the eye	68
Pure laparoscopic donor hepatectomy: Experience of 556 cases at Seoul National University Hospital	67
Impact of interleukin-6 on T cells in kidney transplant recipients	67
Development of a natural language processing algorithm to extract social determinants of health from clinician notes	66
Long-term outcomes after normothermic machine perfusion in liver transplantation—Experience at a single North American center	66
The benefit to waitlist patients in a national paired kidney exchange program: Exploring characteristics of chain end living donor transplants	65
Disparities in liver transplantation: One size may not fit all	65
Dynamic impact of liver allocation policy change on donor utilization	65
SARS-CoV-2 antibody testing for transplant recipients: A tool to personalize protection versus COVID-19	65
Validation of a novel donor lung scoring system based on the updated lung Composite Allocation Score	64
Outside Front Cover	63
An ethical analysis of conditional and partially directed live kidney donation among strangers—The Israeli experience	63
Rejection and graft vasculopathy secondary to effects of Crohn's disease in a heart-transplanted child	62
OPTN/SRTR 2021 Annual Data Report: Lung	62
Generating strategies for a national comeback in pancreas transplantation: A Delphi survey and US conference report	62
The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients	61
Recurrence of membranous nephropathy after kidney transplantation: A multicenter retrospective cohort study	60
Corrigendum to ‘Partial Bladder Transplantation with En Bloc Kidney Transplant—The First Case Report of a ‘Bladder Patch Technique’ in a Human’ [American Journal of Transplantation 8 (2008) 1060-1063]	58
A plan to save lives: Hong Kong–mainland China second-tier mutual assistance allocation	57
Increasing liver organ acquisition fees and the risk of a tragedy of the commons	56
Anatomical variations of left hepatic vein and outflow reconstruction techniques in pediatric living donor liver transplantation	55
Prevention of Mollicute transmitted infections from donor lungs after lung transplant	55
Sex disparity in liver allocation within Eurotransplant	54
Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring	54
Specific human leucocyte antigen-DQ risk epitope mismatches are associated with chronic lung allograft dysfunction after lung transplantation	54
Effectiveness of a culturally competent care intervention in reducing disparities in Hispanic live donor kidney transplantation: A hybrid trial	54
Donor programmed cell death 1 ligand 1 is required for organ transplant tolerance in major histocompatibility complex-mismatched mixed chimeras although programmed cell death 1 ligand 1 and major hist	52
Utilizing pathophysiological concepts of ischemia-reperfusion injury to design renoprotective strategies and therapeutic interventions for normothermic ex vivo kidney perfusion	51
Robotic kidney transplantation from deceased donors: A single-center experience	51
Changes in influenza and other respiratory virus activity during the COVID-19 pandemic—United States, 2020–2021	51
Down to the coronary arteries: When spatial multiomics open up a narrow path	50
Spatial multiomics of arterial regions from cardiac allograft vasculopathy rejected grafts reveal novel insights into the pathogenesis of chronic antibody-mediated rejection	50
Letter in reference to “Economic evaluation of weight loss and transplantation strategies for kidney transplant candidates with obesity”	49
Geographic disparities in access to liver transplant for advanced cirrhosis: Time to ring the alarm!	49
ATC 2024 Poster Abstracts	48
The dangerous precedent of censoring scientific dissemination	48
One Man In His Time Plays Many Parts: Transplant Surgeons’ Approach to Evolution of Career Identity	47
DCD Liver Transplantation- Contemporary US Experience with NRP and NMP	47

Poor Post-Transplantation Renal Function Negatively Impacts Survival of Liver Transplant Recipients Despite SLK and Safety Net Kidney Transplantation	46
Rhabdomyolysis Following Living Donor Kidney Donation - an Underreported Entity?	46
Characterizing Renal Function Predictors and Outcomes in Liver Transplant Recipients Who Have Preoperative Renal Dysfunction	46
Variability in post-transplant outcomes reported by studies examining perfusion techniques in liver transplantation: a qualitative systematic review	45
Intranasal therapy of IGFBP2 ameliorates lung fibrosis	45
Cell-free DNA method for monitoring porcine-to-human xenotransplants	44
Integrating frailty into clinical care	43
Controlled Hypothermic Preservation of Donor Livers with Back- to-Base Normothermic Machine Perfusion Improves Clinical Outcomes and Facilitates Donor Pool Expansion	43
Sowing “seeds of trust”: How trust in normothermic regional perfusion is built in a continuum of care	42
First report of auxiliary liver transplantation for severe cholangiopathy after SARS-CoV-2 respiratory infection	40
SARS-CoV-2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients	40
The impact of machine perfusion of the heart on warm ischemia time and organ yield in donation after circulatory death	40
MELD-based allocation at 20: Can we evolve and mature?	40
Unexpected incidental finding in a prospective living kidney donor	39
The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: A randomized controlled study	39
“Horses for courses” computed tomography or predicted total lung capacity for size matching in lung transplantation	39
Novel modified iliac artery stent graft with side branch extension facilitating kidney transplant in severe aortoiliac occlusive disease	39
Second field high-resolution HLA typing for immunologic risk stratification in kidney transplantation	39
Incomplete tissue product tracing during an investigation of a tissue-derived tuberculosis outbreak	39
Utilization and outcomes of deceased donor SARS-CoV-2–positive organs for solid organ transplantation in the United States	39
Immunosuppressive therapy after solid organ transplantation and the gut microbiota: Bidirectional interactions with clinical consequences	38
“Time is tissue”—A minireview on the importance of donor nephrectomy, donor hepatectomy, and implantation times in kidney and liver transplantation	38
OPTN/SRTR 2023 Annual Data Report: Kidney	38
Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae	38
The short end of the stick: Access to lung transplantation for short-statured patients in the composite allocation score era	37
Back-table intra-arterial administration of C1 esterase inhibitor to deceased donor kidney allografts improves posttransplant allograft function: Results of a randomized double-blind placebo-controlle	37
Normothermic ex situ pancreas perfusion for the preservation of porcine pancreas grafts	36
Oxidative stress and related metabolic alterations are induced in ex situ perfusion of donated hearts regardless of the ventricular load or leukocyte depletion	36
10 degree C static storage of porcine donation after circulatory death livers improves biliary viability and mitigates ischemia-reperfusion injury	36
OPTN/SRTR 2023 Annual Data Report: Lung	36
Characterizing proximity and transfers of deceased organ donors to donor care units in the United States	36
Regarding normothermic regional perfusion: Arguing by insistence is not a strong argument	35
Donor utilization in heart transplant with donation after circulatory death in the United States	35
	34
Body composition and the skeletal muscle compartment in liver transplantation: Turning challenges into opportunities	34
Stem cell–derived islets take a leap toward patients	34
Reply to Letter in reference to Kidney graft directly implanted on endovascular stent in external iliac artery: a preliminary experience	34
The 21st Century Cures Act and psychosocial electronic documentation in solid organ transplantation: Potential harms and practical strategies	34
Adjusting for race in metrics of organ procurement organization performance	34
CDC guidance on new pentavalent meningococcal vaccine	34
Protecting kidney transplant recipients against SARS-CoV-2 infection: A third dose of vaccine is necessary now	33
Targeting CXCR1/2 in the first multicenter, double-blinded, randomized trial in autologous islet transplant recipients	33
Low-dose interleukin-2 promotes immune regulation in face transplantation: A pilot study	33
Macrophage-inducible C-type lectin activates B cells to promote T cell reconstitution in heart allograft recipients	33
Treating comorbidity in solid organ transplant recipients as a confounder or a mediator of patient outcomes	33
Facial skin lesions and diarrhea in a kidney transplant recipient	32
Utilizing kidneys from a donor with bile-cast nephropathy	32
Oropouche virus disease—region of the Americas	32
Pancreas transplantation as rescue therapy in a patient with type 1 diabetes and concurrent subcutaneous insulin resistance	32
A 46-year-old male with posttransplant lymphoproliferative disorder and massive hemoptysis following second bilateral lung transplantation	32
Prognostic implications of lung cancers incidentally identified on explant: A joint study of the Scientific Registry of Transplant Recipients and the National Cancer Database	32
Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients	32
Balancing the live virus vaccine scales: Protection vs risk	32
Trained immunity: Can we get one transplanted kidney to last a lifetime?	32
Continuous donor-recipient age matching: A chance for kidney allocation in the Eurotransplant region	32
Dual JAK2/Aurora kinase A inhibition prevents human skin graft rejection by allo-inactivation and ILC2-mediated tissue repair	31
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS 2nd Edition Dharnidharka Vikas R, Green Michael, Webber Steven A, Ulrich Trappe Ralf (ed.), Switzerland: Springer International Publishing, 2021, XIII, 31	31
The current state of transplant advanced practice providers: results of the advanced practice provider practice survey	31
OPTN/SRTR 2022 Annual Data Report: COVID-19	31
Transplant oncology in locally advanced intrahepatic cholangiocarcinoma: One more step on a long road	31
Keep the engine running: Maintaining transplant registry utility in liver transplant	30
Upper gastrointestinal bleeding in a lung transplant recipient	30
Outside Front Cover	30
The impact of visitation volunteers on the mood, valence, and arousal of liver and kidney transplant patients	29
CD47 and PD-L1 overexpression in proliferating human hepatocytes attenuated immune responses and ameliorated acute liver injury in mice	29
Circadian clocks drive rhythmic antitumor immune responses mediated by migratory dendritic cells	29
AWAKE Program with rapid discharge in Kidney Transplantation	29
The Role of Race and Socioeconomic Status in Live Donor Kidney Transplant Interest and Evaluation	29
Impact of the new UNOS donor heart allocation system on waitlist outcomes and early posttransplant mortality among adults with congenital heart disease	29
What Can We Learn from analyzing Paired Mate Kidneys Transplanted at the Same Center?	29
Outcomes of Single Pediatric Kidney Grafts	29
Front Page	29
Generalizability of kidney transplant data in electronic health records — The Epic Cosmos database vs the Scientific Registry of Transplant Recipients	29
Total pancreatectomy with islet cell autotransplantation in a 2-year-old child with hereditary pancreatitis due to a PRSS1 mutation	28
In a real-life setting, risk factors, coronary artery calcium score, and coronary stenosis at computed tomography angiography are associated with major adverse cardiovascular events and all-cause mort	28
Transplantation, HIV Serostatus, and Registry Data: Room for Improvement	28
Letter in reference to “Neoadjuvant Pemigatinib as a Bridge to Living Donor Liver Transplantation for Intrahepatic Cholangiocarcinoma with FGFR2 Rearrangement”	28
Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus — RSV-NET, 12 States, July 2022–June 2023	28
Hemophagocytic syndrome with graft-versus-host disease after liver transplantation: The bone marrow as a not so quiet battlefield?	28
Subphenotypes of frailty in lung transplant candidates	28

Clear data, careful counseling: Discussing cancer risk after living kidney donation	28
OPTN/SRTR 2021 Annual Data Report: Deceased Organ Donation	27
Letermovir in lung transplant recipients with cytomegalovirus infection: A retrospective observational study	27
Molecular diagnosis of antibody-mediated rejection: Evaluating biopsy-based transcript diagnostics in the presence of donor-specific antibodies but without microvascular inflammation, a single-center	27
TIGIT agonism alleviates costimulation blockade-resistant rejection in a regulatory T cell–dependent manner	27
Liver transplantation for acute liver failure and acute-on-chronic liver failure	27
Exploring the Potential of Machine Learning in Predicting Primary Graft Dysfunction Post-Lung Transplantation	26
Impact of kidney function on 200 days of antiviral prophylaxis for cytomegalovirus disease in CMV-seronegative recipients of CMV-seropositive donor kidneys Post hoc analysis of a randomized, phase 3 t	26
Motivations and outcomes of compatible living donor–recipient pairs in paired exchange	26
The landscape of hepatitis C virus infection in pediatric kidney transplantation	26
Effects of broader geographic distribution of donor lungs on travel mode and estimated costs of organ procurement	26
Letter to the Editor: Modernization Without Transparency: Our Decision to Resign from the OPTN Board	26
OPTN/SRTR 2020 Annual Data Report: Lung	25
Impact of Normothermic Machine Perfusion on Liver Transplant Waitlist Times: A Single-Center Matched Cohort	25
Importance of malnutrition and frailty in kidney transplant waiting list	25
The living organ donor as patient: Theory and practice	25
Bioengineered Organs: Not a Matter of “If”	25
Outcomes in Patients with Incidental Intra-hepatic Cholangiocarcinoma on Explant Pathology after Liver Transplantation	25
Managing Bile Duct and Vascular Variations in Robotic Assisted Living Donor Right Hepatectomy: A Single Center U.S. Experience	25
	25
The thymus hosts liver- and gut-like mimetic cells critical to immune self-tolerance	25
The Comparison of Cellular and Acellular Perfusate for the Dynamic Organ Storage System in a Porcine Donation After Circulatory Death Model	25
The individual impact of machine perfusion on liver and kidney in simultaneous liver and kidney transplantation	25
	25
Deceased donor urinary Dickkopf-3 associates with future allograft function following kidney transplantation	24
OPTN/SRTR 2023 Annual Data Report: Intestine	24
When is it safe to transplant after cancer–adding data to the decision	24
Donor-specific immune senescence as a candidate biomarker of operational tolerance following liver transplantation in adults: Results of a prospective, multicenter cohort study	24
Mortality among solid organ transplant recipients with a pretransplant cancer diagnosis	24
The role of IL-6 in hyperlipidemia-induced accelerated rejection	24
Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximab	24
The concept of immunothrombosis in pancreas transplantation	24
Graft function and incidence of cardiac allograft vasculopathy in donation after circulatory-determined death heart transplant recipients	23
Iron deficiency, anemia, and patient-reported outcomes in kidney transplant recipients	23
Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial	23
From flawed to fairer: Reducing blood type bias in lung transplant allocation	23
Surgical site infections after kidney transplantation are independently associated with graft loss	23
Evaluation for genetic disease in kidney transplant candidates: A practice resource	23
Tongue ulcer in a pediatric heart transplant recipient	23
Belatacept-related cytomegalovirus infection: Advocacy for tailored immunosuppression based on individual assessment of immune fitness	23
A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppression	23
White paper on antimicrobial stewardship in solid organ transplant recipients	23
Correcting the sex disparity in MELD-Na	23
Diagnosis and treatment of allograft rejection in islet transplantation	23
Humoral immune responses against SARS-CoV-2 in transplantation: Actionable biomarker or misplaced trust?	23
Augmenter of liver regeneration-mediated mitophagy protects against hepatic ischemia/reperfusion injury	22
Gene expression–based molecular scoring of pancreas transplant rejection for a quantitative assessment of rejection severity and resistance to treatment	22
OPTN/SRTR 2022 Annual Data Report: Heart	22
Graft-resident donor macrophages functionally regulate transplant outcomes	22
Transplantation pushes into the world of elite sports	22
A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients	22
The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study	22
Solid organ transplant recipients with tuberculosis disease in California, 2010 to 2020	22
American Journal of Transplantation: Volume 22, Number 2, February 2022	22
Unexpected hepatitis B virus infection after liver transplantation — United States, 2014–2019	22
The role of bypass filters in deceased donor kidney allocation in the United States	22
Sensitization in Transplantation Assessment of Risk 2025 innate working group: The potential role of innate allorecognition in kidney allograft damage	22
American Journal of Transplantation: Volume 21, Number 10, October 2021	22
ATC 2023 DAAG_Program	22
Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death	21
OPTN/SRTR 2022 Annual Data Report: Pancreas	21
Corrigendum to ‘Criteria for prediabetes and posttransplant diabetes mellitus after kidney transplantation: A 2-year diagnostic accuracy study of participants from a randomized controlled trial’ [Amer	21
Therapeutic Hypothermia vs Normothermia in Kidney Transplantation: A Meta-analysis of Randomized Controlled Trials	21
T Cell repopulation after using rATG in a Decedent Xenotransplant Study	21
Machine learning–based mortality prediction models using national liver transplantation registries are feasible but have limited utility across countries	21
OPTN/SRTR 2022 Annual Data Report: Deceased Organ Donation	21
Macrophage-specific hypoxia inducible factor 2α expression promotes cardiac allograft tolerance	21
Characteristics and Outcomes of Kidneys Accepted versus Turned Down by Regional Centers	21
Corrigendum to ‘Assessment of long-term outcomes post living liver donation highlights the importance of scientific integrity when presenting transplant registry data’ [American Journal of Transplanta	21
Intragraft B cell differentiation during the development of tolerance to kidney allografts is associated with a regulatory B cell signature revealed by single cell transcriptomics	21
Banff 2022 Vascularized Composite Allotransplantation Meeting Report: Diagnostic criteria for vascular changes	21
Measuring success in pig to non-human-primate renal xenotransplantation: Systematic review and comparative outcomes analysis of 1051 life-sustaining NHP renal allo- and xeno-transplants	21
Expedited lung allocation in the era of continuous distribution	21
Book review	20
BK DNAemia and native kidney polyomavirus nephropathy following lung transplantation	20
Repeat SARS-CoV-2 testing after recovery. Is a pretransplant PCR necessary?	20
Liver Transplantation for Fulminant Hepatic Failure in a Young Woman	20
Orthotopic robot-assisted laparoscopic kidney transplantation with living donor: An option for patients excluded from standard heterotopic transplantation	20
Preemptive intravenous human immunoglobulin G suppresses BK polyomavirus replication and spread of infection in vitro	20
Multivisceral transplantation utilizing hepatitis C virus–viremic donors for hepatitis C virus–negative recipients	20
Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations	20
OPTN/SRTR 2021 Annual Data Report: Introduction	20
West Nile Virus and Other Nationally Notifiable Arboviral Diseases — United States, 2023	20
OPTN/SRTR 2022 Annual Data Report: Intestine	20
Wanted: An endothelial cell targeting atlas for nanotherapeutic delivery in allograft organs	19
Response to “Public attitude to imminent death donation”	19
Hepatitis C–associated focal proliferative glomerulonephritis in an aviremic recipient of a hepatitis C–positive antibody donor liver	19
The impact of islet mass, number of transplants, and time between transplants on graft function in a national islet transplant program	19
Caregiver COVID-19 vaccination for solid organ transplant candidates	19
Chimeric autoantibody-receptor T cells mediate depletion of autoantibody-producing B cells	19
Recipient sex and estradiol levels affect transplant outcomes in an age-specific fashion	19
Time to reconsider the role of donor hepatitis C status in the Kidney Donor Risk Index	19
Multiple liver lesions in a lung transplant recipient	19
Normothermic Machine Perfusion Facilitates Donation After Circulatory Death Liver Transplant In High-Risk Recipients	19
Association of organ procurement organization volume with Centers for Medicare and Medicaid Services performance evaluations	19